Penserra Capital Management LLC Gossamer Bio, Inc. Transaction History

Penserra Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$10.12 - $14.07 $17,558 - $24,411	-1,735 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$7.25 - $13.23 $36 - $66	5 Added 0.29%	1,735 $21,000
Q2 2021 Aug 12, 2021	BUY	$8.0 - $9.75 $160 - $195	20 Added 1.17%	1,730 $14,000
Q1 2021 May 13, 2021	SELL	$8.63 - $10.94 $388 - $492	-45 Reduced 2.56%	1,710 $15,000
Q4 2020 Feb 12, 2021	BUY	$8.3 - $13.59 $9,188 - $15,044	1,107 Added 170.83%	1,755 $16,000
Q3 2020 Nov 13, 2020	BUY	$11.3 - $14.75 $7,322 - $9,558	648 New	648 $8,000

116

163M

821K

557K

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $132M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.